메뉴 건너뛰기




Volumn 83, Issue 1, 2015, Pages 53-55

Microbiological activity of ceftolozane/tazobactam, ceftazidime, meropenem, and piperacillin/tazobactam against Pseudomonas aeruginosa isolated from children with cystic fibrosis

Author keywords

Antibiotic; Beta lactam; Cystic fibrosis; Pseudomonas; Susceptibility

Indexed keywords

CEFTAZIDIME; CEFTOLOZANE PLUS TAZOBACTAM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; BETA LACTAM;

EID: 84938739520     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2015.04.012     Document Type: Article
Times cited : (38)

References (9)
  • 1
    • 84901280909 scopus 로고    scopus 로고
    • Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC
    • Cabot G., Bruchmann S., Mulet X., Zamorano L., Moyá B., Juan C., et al. Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC. Antimicrob Agents Chemother 2014, 58:3091-3099.
    • (2014) Antimicrob Agents Chemother , vol.58 , pp. 3091-3099
    • Cabot, G.1    Bruchmann, S.2    Mulet, X.3    Zamorano, L.4    Moyá, B.5    Juan, C.6
  • 5
    • 84880714505 scopus 로고    scopus 로고
    • Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study
    • Llanes C., Pourcel C., Richardot C., Plésiat P., Fichant G., Cavallo J.D., et al. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study. J Antimicrob Chemother 2013, 68:1763-1771.
    • (2013) J Antimicrob Chemother , vol.68 , pp. 1763-1771
    • Llanes, C.1    Pourcel, C.2    Richardot, C.3    Plésiat, P.4    Fichant, G.5    Cavallo, J.D.6
  • 6
    • 77954180134 scopus 로고    scopus 로고
    • Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1
    • Riera E., Macia M.D., Mena A., Mulet X., Perez J.L., Ge Y., et al. Anti-biofilm and resistance suppression activities of CXA-101 against chronic respiratory infection phenotypes of Pseudomonas aeruginosa strain PAO1. J Antimicrob Chemother 2010, 65:1399-1404.
    • (2010) J Antimicrob Chemother , vol.65 , pp. 1399-1404
    • Riera, E.1    Macia, M.D.2    Mena, A.3    Mulet, X.4    Perez, J.L.5    Ge, Y.6
  • 7
    • 77955637131 scopus 로고    scopus 로고
    • Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolated from chronically-infected cystic fibrosis patients
    • Zamorano L., Juan C., Fernández-Olmos A., Ge Y., Cantón R., Oliver A. Activity of the new cephalosporin CXA-101 (FR264205) against Pseudomonas aeruginosa isolated from chronically-infected cystic fibrosis patients. Clin Microbiol Infect 2010, 16:1482-1487.
    • (2010) Clin Microbiol Infect , vol.16 , pp. 1482-1487
    • Zamorano, L.1    Juan, C.2    Fernández-Olmos, A.3    Ge, Y.4    Cantón, R.5    Oliver, A.6
  • 9
    • 84893029558 scopus 로고    scopus 로고
    • Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli
    • Zhanel G., Chung P., Adam H., Zelenitsky S., Denisuik A., Schweizer F., et al. Ceftolozane/tazobactam: a novel cephalosporin/β-lactamase inhibitor combination with activity against multidrug-resistant gram-negative bacilli. Drugs 2014, 74:31-51.
    • (2014) Drugs , vol.74 , pp. 31-51
    • Zhanel, G.1    Chung, P.2    Adam, H.3    Zelenitsky, S.4    Denisuik, A.5    Schweizer, F.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.